Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$24.03 - $27.02 $180,225 - $202,650
-7,500 Reduced 4.59%
155,900 $4.2 Million
Q3 2022

Nov 14, 2022

SELL
$11.6 - $20.44 $1.11 Million - $1.96 Million
-96,100 Reduced 37.03%
163,400 $2.94 Million
Q2 2022

Aug 15, 2022

BUY
$7.78 - $14.69 $861,246 - $1.63 Million
110,700 Added 74.4%
259,500 $3.23 Million
Q1 2022

May 16, 2022

BUY
$11.38 - $16.4 $19,346 - $27,879
1,700 Added 1.16%
148,800 $1.98 Million
Q4 2021

Feb 14, 2022

SELL
$14.31 - $23.87 $794,205 - $1.32 Million
-55,500 Reduced 27.39%
147,100 $2.29 Million
Q3 2021

Nov 15, 2021

BUY
$18.94 - $26.99 $223,492 - $318,482
11,800 Added 6.18%
202,600 $4.55 Million
Q2 2021

Aug 11, 2021

BUY
$17.07 - $24.56 $2.07 Million - $2.97 Million
121,100 Added 173.74%
190,800 $4.35 Million
Q1 2021

May 17, 2021

SELL
$20.46 - $25.18 $343,728 - $423,024
-16,800 Reduced 19.42%
69,700 $1.43 Million
Q4 2020

Feb 16, 2021

BUY
$13.8 - $27.62 $931,500 - $1.86 Million
67,500 Added 355.26%
86,500 $2.39 Million
Q3 2020

Nov 16, 2020

BUY
$14.05 - $22.6 $37,935 - $61,020
2,700 Added 16.56%
19,000 $267,000
Q2 2020

Aug 14, 2020

SELL
$7.34 - $20.84 $342,778 - $973,228
-46,700 Reduced 74.13%
16,300 $336,000
Q4 2019

Feb 14, 2020

BUY
$4.2 - $19.21 $264,600 - $1.21 Million
63,000 New
63,000 $978,000

Others Institutions Holding MYOV

About Myovant Sciences Ltd.


  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.